OFS (ovarian function suppression)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OFS (ovarian function suppression), covering 2025-05-22 to 2025-05-22. Get the full timeline:
Most recent: Clinical Trial Update: OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk [Phase 4]